Evidence map›Paper›PMID 30301489›Full record

ArticleEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin2018

Summary of available surveillance data on hepatitis C virus infection from eight Arctic countries, 2012 to 2014.

Prabhu P Gounder, Anders Koch, Ginger Provo, Astrid Lovlie, Josefine Lundberg Ederth, Maria Axelsson, Chris P Archibald, Brendan Hanley, Angie Mullen, Myrna Matheson and 6 more

Abstract read
In one paragraph

Article in Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Prabhu P GounderArctic Investigations Program, Division of Preparedness and Emerging Infections, National Center for Emerging and Zoonotic Infectious Diseases, U.S. Centers for Disease Control and Prevention (CDC), Anchorage, Alaska, USA.
Anders KochStatens Serum Institut, Copenhagen, Denmark.
Ginger ProvoDivision of Public Health, State of Alaska, Anchorage, Alaska, USA.
Astrid LovlieDepartment for Infectious Disease Registries, Norwegian Institute of Public Health, Oslo, Norway.
Josefine Lundberg EderthDepartment of Public Health Analysis and Data Management, Public Health Agency of Sweden, Stockholm, Sweden.
Maria AxelssonUnit for Epidemiology & Health Economic, the Public Health Agency of Sweden, Stockholm, Sweden.
Chris P ArchibaldSurveillance and Epidemiology Division, Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada, Ottawa, Canada.
Brendan HanleyChief Medical Officer of Health, Whitehorse, Yukon, Canada.
Angie MullenDepartment of Health, Government of Nunavut, Iqaluit, Nunavut, Canada.
Myrna MathesonCommunicable Disease Control Unit, Department of Health and Social Services, Government of the Northwest Territories, Yellowknife, Northwest Territories, Canada.
David AllisonDepartment of Health and Community Services, St. John's, Newfoundland and Labrador, Canada.
Henrik TrykkerNational Board of Health, Nuuk, Greenland.
Thomas W HennessyArctic Investigations Program, Division of Preparedness and Emerging Infections, National Center for Emerging and Zoonotic Infectious Diseases, U.S. Centers for Disease Control and Prevention (CDC), Anchorage, Alaska, USA.
Markku KuusiNational Institute for Health and Welfare (THL), Helsinki, Finland.
Vladimir ChulanovCentral Research Institute of Epidemiology, Reference Center for Viral Hepatitis, Moscow, Russia.
Brian J McMahonArctic Investigations Program, Division of Preparedness and Emerging Infections, National Center for Emerging and Zoonotic Infectious Diseases, U.S. Centers for Disease Control and Prevention (CDC), Anchorage, Alaska, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We summarised available hepatitis C virus (HCV) surveillance data for 2012-14 from Arctic/sub-Arctic countries/regions. We sent a HCV data collection template by email to public health authorities in all jurisdictions. Population statistics obtained from census sources for each country were used to estimate rates of reported acute and chronic/undifferentiated HCV cases. Seven countries with Arctic regions (Canada, Denmark, Finland, Greenland, Norway, Sweden and the United States, represented by the state of Alaska), including three Canadian territories and one province, as well as 11 Russian subnational Arctic regions, completed the data collection template. Data on acute HCV infection during 2014 was available from three Arctic countries and all Russian Arctic regions (rate range 0/100,000 population in Greenland, as well as Nenets and Chukotka Automous Okrugs (Russian subnational Arctic regions) to 3.7/100,000 in the Russian Republic of Komi). The rate of people with chronic/undifferentiated HCV infection in 2014 ranged from 0/100,000 in Greenland to 171.2/100,000 in Alaska. In most countries/regions, the majority of HCV-infected people were male and aged 19-64 years. Differences in surveillance methods preclude direct comparisons of HCV surveillance data between Arctic countries/regions. Our data can inform future efforts to develop standardised approaches to HCV surveillance in the Arctic countries/regions by identifying similarities/differences between the surveillance data collected.

Indexed as

HepacivirusAdultAgedArctic RegionsFemaleHepatitis CHumansMaleMiddle AgedPopulation SurveillancePrevalenceYoung Adultindigenous populationsNorth Americanorthern Europeprevention and controlsurveillanceviral hepatitis

Identifiers

PMID30301489
PMCPMC6178586

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.